Planning for the Romanian clinical trial

Members of the Dermaflow team - Dr Irene Jaffe, Ilya Skoletsky, Dr Danny Weiss, Dr Mehmet Hendekli and Stephen Jacobs meet with the investigators from the CC Iliescu Emergency Institute for Cardiovascular Diseases, Bucharest, Romania  to review the plans for the clinical trial, due to commence January 2017

Read More
Irene Jaffe
Demonstration of the new Perichek Multi™ device

Ilya Skoletsky demonstrates the new Perichek Multi peripheral blood flow monitor to Professor Serban Bubenek and Dr Ion Miclea from the CC Iliescu Emergency Institute for Cardiovascular Diseases  Bucharest, Romania in preparation for the clinical trial due to commence January 2017.

Read More
Irene Jaffe
Product Testing and Clinical Trials

· Testing by Vital Motion of DermaFlow prototypes together with their VM-100 marketed product to add monitoring functionality to their therapeutic OTC device

· Initiation of first sports injury study with ParFlow™ at SportsClinic, and MIS Orthopedic Clinic, Thessaloniki,

· Initiation (in November) of first clinical trial dedicated to ICU sepsis patients at CC Iliescu Emergency Institute for Cardiovascular Diseases (part of the Fundeni Clinical Institute) Bucharest, Romania

Read More
Irene Jaffe
Licensing Agreements

· Exclusive licensing agreement with Parallel Biotechnologies to provide DermaFlow all rights to the jointly developed ParFlow™ product world-wide

· Letter of Intent discussions underway today with Vital Motion – following a testing program - which will form basis for licensing agreement

Read More
Irene Jaffe